DEPDC1 and cancer: Thus, further studies are needed to investigate whether rational combination of DEPDC1 siRNA or inhibitors with the IKK/NF-κB inhibitors or chemotherapeutic agents will achieve a synergistic antitumor effect in NPC as well as other types of cancers.